QT Imaging (NASDAQ:QTI), Inc. (NASDAQ:QTI) is a medical imaging company specializing in advanced cardiovascular diagnostic solutions for veterinary and small animal practices. Its core offerings include integrated ultrasound imaging systems, digital electrocardiography platforms and complementary software tools designed to streamline cardiac assessments. By combining real-time imaging with automated data analysis, QT Imaging enables practitioners to perform comprehensive cardiac exams with improved accuracy and efficiency.
The company’s product portfolio features high-resolution ultrasound consoles, modular ECG machines and proprietary analysis software that supports a range of diagnostic procedures, from routine wellness screenings to complex arrhythmia evaluations. QT Imaging also offers cloud-based data management and remote monitoring services, allowing veterinary clinics to share and review cases with specialists across different regions. Training programs and technical support play a central role in its go-to-market approach, ensuring end users can maximize the diagnostic capabilities of its platforms.
Founded in the late 2000s and headquartered in Massachusetts, QT Imaging has expanded its footprint through a network of authorized distributors and strategic partnerships. Its solutions are deployed in facilities across North America, Europe and the Asia-Pacific region, serving academic research centers, specialty referrals and general practice clinics. The company continues to invest in research and development to address emerging trends in veterinary cardiology and to maintain compliance with regulatory standards in its target markets.
QT Imaging is led by a management team with deep expertise in medical device innovation, veterinary medicine and global sales. This leadership group oversees company operations, product development and commercial strategy, leveraging decades of industry experience to drive growth and technological advancement in animal cardiac care. With a focus on quality, support and collaborative research, the company aims to enhance diagnostic outcomes and veterinary practice efficiencies worldwide.
